4 results match your criteria: "Center for Palliative Care Hildegard[Affiliation]"
Heart
June 2023
Institute of Health Economics and Clinical Epidemiology, University Hospital Cologne, Cologne, Germany.
Background: For the treatment of breathlessness in heart failure (HF), most textbooks advocate the use of opioids. Yet, meta-analyses are lacking.
Methods: A systematic review was performed for randomised controlled trials (RCTs) assessing effects of opioids on breathlessness (primary outcome) in patients with HF.
Support Care Cancer
November 2020
Center for Palliative Care Hildegard, Basel, Switzerland.
Purpose: The aim of this study was to identify symptoms of severe intensity or very low scores for quality of life (QoL) domains in newly diagnosed outpatients with advanced cancer.
Methods: This multicenter cohort study from a state-wide palliative care network included adult outpatients with advanced cancer diagnosed within the preceding 8 weeks from four comprehensive cancer centers (DRKS00006162, registered on 19 May 2014). We used the Palliative Outcome Scale (POS), Hospital Anxiety and Depression Scale, and European Organization for Research and Treatment of Cancer QoL Questionnaire-C30.
Support Care Cancer
November 2020
Center for Palliative Care Hildegard, Basel, Switzerland.
Purpose: Transcutaneous electrical nerve stimulation (TENS) is a treatment option for cancer pain, but the evidence is inconclusive. We aimed to evaluate the efficacy and safety of TENS.
Methods: A blinded, randomized, sham-controlled pilot cross-over trial (NCT02655289) was conducted on an inpatient specialist palliative care ward.
Ann Palliat Med
April 2019
Center for Palliative Care Hildegard, Basel, Switzerland.
Background: In advanced cancer, quality of life (QoL) is a major treatment goal. In order to achieve this, the identification of suffering by screening for patient-reported-outcomes (PROs, i.e.
View Article and Find Full Text PDF